Skip to Content

MYLAN 2537 MYLAN 2537 (Hydrochlorothiazide and Triamterene 25 mg / 37.5 mg)

Pill with imprint MYLAN 2537 MYLAN 2537 is Green & Yellow, Capsule-shape and has been identified as Hydrochlorothiazide and Triamterene 25 mg / 37.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Hydrochlorothiazide/triamterene is used in the treatment of edema; high blood pressure and belongs to the drug class potassium sparing diuretics with thiazides. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/triamterene 25 mg / 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2537 MYLAN 2537

Hydrochlorothiazide and triamterene 25 mg / 37.5 mg MYLAN 2537 MYLAN 2537
Hydrochlorothiazide and triamterene 25 mg / 37.5 mg MYLAN 2537 MYLAN 2537
Hydrochlorothiazide and triamterene 25 mg / 37.5 mg MYLAN 2537 MYLAN 2537
Hydrochlorothiazide and triamterene 25 mg / 37.5 mg MYLAN 2537 MYLAN 2537 Front
Hydrochlorothiazide and triamterene 25 mg / 37.5 mg MYLAN 2537 MYLAN 2537 Back
Hydrochlorothiazide and triamterene 25 mg / 37.5 mg MYLAN 2537 MYLAN 2537

Hydrochlorothiazide and Triamterene

Imprint
MYLAN 2537 MYLAN 2537
Strength
25 mg / 37.5 mg
Color
Green & Yellow
Size
12.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Potassium sparing diuretics with thiazides
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, polysorbate 80, propylene glycol, sodium bicarbonate, sodium lauryl sulfate, ferrosoferric oxide, titanium dioxide, ferric oxide yellow, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-2537 Mylan Pharmaceuticals Inc.
51079-0935 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.